Vienna, Austria · Founded 2017 · Privately Held (backing)
Developer of DNA technologies designed to meet the tailored needs of synthetic biology. Ribbon Bio is based in Vienna, Austria and was founded in 2017. Its last reported valuation was $46.6 million in Feb 2025. It has raised $27.3 million.
Last reported valuation
$46.6M
Oct 2026
Priced at
—
Total raised
$27.3M
Last round
—
Cap table — not yet on record
Ribbon Bio's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Ribbon Bio with a free account
·Watch Ribbon Bio: the Monday email on marks, rounds and moves
